Microlasers, which are tiny laser devices used in optical technologies, can quickly switch between different lasing states. These states compete within the microcavity, and changes in external conditions can cause the laser to abruptly jump from one mode to another. This switching process is not gradual but occurs suddenly and …
Researchers have developed improved lateral flow assays that allow pet owners to quickly test for feline panleukopenia and canine parvovirus at home. These viruses can cause severe illness in cats and dogs, presenting symptoms such as digestive issues, lethargy, and fever. The new test strips showed 100% sensitivity and consistent …
Researchers from the UK and Japan have used a machine-learning algorithm to propose several potential locations for the Soviet Luna 9 spacecraft’s landing site, which has remained unidentified for decades. The study, led by Lewis Pinault at University College London, was published in npj Space Exploration. The team plans to …
SpaceX CEO Elon Musk announced on Sunday that the company is redirecting its efforts from Mars exploration to developing infrastructure on the Moon. Musk outlined plans to create “self-growing bases” and factories on the lunar surface, aiming to establish a sustainable human presence closer to Earth. This new direction emphasizes …
A new white paper from Thermo Fisher Scientific outlines how integrating advanced technologies can speed up early-stage biologic development. By leveraging artificial intelligence and machine learning (AI/ML), enhanced cell line development, and intensified manufacturing processes, developers can reduce the time needed to reach Investigational New Drug (IND) applications and first-in-human …
The James Webb Space Telescope (JWST) has identified a massive galaxy that existed just 400 million years after the Big Bang. This discovery provides new insights into the early stages of galaxy formation in the universe. The galaxy’s size and structure challenge previous assumptions about how quickly large galaxies could …
IGC Pharma has announced the expansion of its Phase 2 CALMA clinical trial to include the renowned GNA site in Colombia. This addition aims to enhance the genetic diversity of trial participants and support the company’s goal of advancing its Alzheimer’s treatment development. The inclusion of the GNA site, recognized …
IGC Pharma has announced the inclusion of a prominent research center in Colombia into its ongoing Phase 2 CALMA clinical trial for Alzheimer’s disease. This addition aims to increase the genetic diversity of trial participants and enhance the robustness of the study’s findings. The new site, recognized globally for its …
IGC Pharma has announced the expansion of its Phase 2 CALMA clinical trial to include a prominent research center in Colombia. This addition aims to increase the genetic diversity of trial participants and enhance the robustness of the study’s findings. The new site, recognized globally for its expertise in genetics …
IGC Pharma has announced the expansion of its Phase 2 CALMA clinical trial to include a prominent research center in Colombia, known for its expertise in Alzheimer’s disease. This addition aims to increase the genetic diversity of trial participants and enhance the overall study quality. The inclusion of the Colombian …